Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Ventyx Biosciences, a clinical-stage biopharmaceutical company, announced its participation in upcoming investor conferences. The company focuses on developing oral therapies for inflammatory diseases. Executives will provide company insights during the 2022 Wells Fargo Healthcare Conference on September 9, 2022, at 8:00 AM ET in Boston, MA, and at the Morgan Stanley 20th Annual Global Healthcare Conference on September 14, 2022, at 4:40 PM ET in New York, NY. Webcasts of the presentations will be available on their website.

ENCINITAS, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that Company executives will host investor meetings and provide a company overview during fireside chats at the following upcoming investor conferences:

• Event: 2022 Wells Fargo Healthcare Conference
  Location: Boston, MA
  Date: Friday, September 9, 2022
  Time: 8:00-8:30 AM ET
  
  
• Event: Morgan Stanley 20^th Annual Global Healthcare Conference
  Location: New York, NY
  Date: Wednesday, September 14, 2022
  Time: 4:40-5:10 PM ET

Webcasts of both presentations will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com. A webcast replay will also be available on this website shortly after conclusion of each event for 30 days.

About Ventyx Biosciences
Ventyx is a clinical-stage biopharmaceutical company focused on developing innovative oral medicines for patients living with autoimmune and inflammatory disorders. We believe our ability to efficiently discover and develop differentiated drug candidates will allow us to address important unmet medical need with novel oral therapies that can shift immunology markets from injectable to oral drugs. Our current pipeline includes three clinical-stage internally discovered programs targeting TYK2, S1P1R and NLRP3, positioning us to become a leader in the development of oral immunology therapies. Ventyx is headquartered in Encinitas, California. For more information about Ventyx, please visit www.ventyxbio.com.

Investor Relations Contact
Patti Bank
Managing Director
ICR Westwicke
(415) 513-1284
IR@ventyxbio.com

 

FAQ

What conferences will Ventyx Biosciences attend in September 2022?

Ventyx Biosciences will attend the Wells Fargo Healthcare Conference on September 9, 2022, and the Morgan Stanley 20th Annual Global Healthcare Conference on September 14, 2022.

What is the focus of Ventyx Biosciences?

Ventyx Biosciences focuses on developing novel oral therapies for autoimmune and inflammatory diseases.

When is the Wells Fargo Healthcare Conference?

The Wells Fargo Healthcare Conference is on September 9, 2022, from 8:00 to 8:30 AM ET.

When can I watch the webcasts of Ventyx's presentations?

Webcasts of Ventyx's presentations will be available on their website shortly after each event and will remain accessible for 30 days.

What time is Ventyx's presentation at the Morgan Stanley conference?

Ventyx's presentation at the Morgan Stanley 20th Annual Global Healthcare Conference is scheduled for September 14, 2022, from 4:40 to 5:10 PM ET.